No. of Pages: 74 | Report Code: BMIRE00031031 | Category: Life Sciences
No. of Pages: 74 | Report Code: BMIRE00031031 | Category: Life Sciences
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - South & Central America Analysis
5.1 South & Central America Opioids Market Revenue (US$ Million), 2020-2030
5.2 South & Central America Opioids Market Forecast Analysis
6. South & Central America Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. South & Central America Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Opioids Market - Country Analysis
10.1 South & Central America
10.1.1 South & Central America Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
10.1.2 South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.2.1 South & Central America: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.2.2 Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Brazil: South & Central America Opioids Market Breakdown, by Product
10.1.2.2.2 Brazil: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.2.3 Brazil: South & Central America Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.2.2.4 Brazil: South & Central America Opioids Market Breakdown, by Application
10.1.2.2.5 Brazil: South & Central America Opioids Market Breakdown, by Route of Administration
10.1.2.2.6 Brazil: South & Central America Opioids Market Breakdown, by Distribution Channel
10.1.2.3 Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Argentina: South & Central America Opioids Market Breakdown, by Product
10.1.2.3.2 Argentina: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.3.3 Argentina: South & Central America Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.2.3.4 Argentina: South & Central America Opioids Market Breakdown, by Application
10.1.2.3.5 Argentina: South & Central America Opioids Market Breakdown, by Route of Administration
10.1.2.3.6 Argentina: South & Central America Opioids Market Breakdown, by Distribution Channel
10.1.2.4 Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Rest of South & Central America: Opioids Market Breakdown, by Product
10.1.2.4.2 Rest of South & Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.4.3 Rest of South & Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.2.4.4 Rest of South & Central America: Opioids Market Breakdown, by Application
10.1.2.4.5 Rest of South & Central America: Opioids Market Breakdown, by Route of Administration
10.1.2.4.6 Rest of South & Central America: Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Rusan Pharma Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. South & Central America Opioids Market Segmentation
Table 2. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 13. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Recent Organic Growth Strategies in Opioids Market
Table 29. Recent Inorganic Growth Strategies in the Opioids Market
Table 30. Glossary of Terms, Opioids Market
List of Figures
Figure 1. South & Central America Opioids Market Segmentation, by Country
Figure 2. South & Central America Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. South & Central America Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. South & Central America Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 23. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Growth Strategies in Opioids Market